The beginning of a new era in medicine: The U.S. FDA has today approved cell-based gene therapy Casgevy, marking the first FDA-approved therapy utilising the genome editing technology CRISPR (NASDAQ:CRSP) | https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease
#FDA #CRISPR #shorts
EDE
0.087
33.8%
LUX
0.24
-28.4%
DAL
0.1
33.3%
NGX
0.051
-27.1%
BOA
0.19
22.6%
EGR
0.225
-22.4%
PV1
0.006
20%
FEL
0.004
-20%
SEA
1.85
18.2%
SRJ
0.004
-20%
CXZ
0.026
18.2%
IBX
0.006
-14.3%
KZR
0.162
15.7%
PNT
0.006
-14.3%
AUV
0.008
14.3%
EXR
0.066
-13.2%
FAU
0.18
12.5%
CTO
0.015
-11.8%
FMN
0.135
12.5%
AON
0.053
-11.7%
MHC
0.018
12.5%
SKS
9.91
-11.3%
TAS
0.029
11.5%
KRM
0.019
-9.5%
AEU
0.4
11.1%
A4N
0.6
-9.1%
GAS
0.01
11.1%
NRL
0.013
-7.1%
MLS
0.02
11.1%
RCR
0.013
-7.1%
BKT
0.011
10%
DAI
0.27
-6.9%
SNT
0.022
10%
AR1
0.07
-6.7%
SNX
0.115
9.5%
LML
0.014
-6.7%
ATV
0.012
9.1%
MTM
0.285
-6.6%
SHE
0.012
9.1%
CMD
0.015
-6.3%
